Principles of percutaneous paravalvular leak closure.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 22361595)

Published in JACC Cardiovasc Interv on February 01, 2012

Authors

Charanjit S Rihal1, Paul Sorajja, Jeffrey D Booker, Donald J Hagler, Allison K Cabalka

Author Affiliations

1: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. rihal@mayo.edu

Articles citing this

Percutaneous retrograde transfemoral closure of mitral paravalvular leak in 3 patients without construction of an arteriovenous wire loop. Tex Heart Inst J (2014) 1.05

Why is intracardiac echocardiography helpful? Benefits, costs, and how to learn. Eur Heart J (2013) 0.88

Percutaneous closure of complex paravalvular aortic root pseudoaneurysm and aorta-cavitary fistulas. Indian Heart J (2014) 0.80

Percutaneous closure of a large aortic paravalvular leak using two duct occluder devices. Indian Heart J (2013) 0.80

Recent advances in echocardiography for valvular heart disease. F1000Res (2015) 0.75

Retrograde Transcatheter Closure of Mitral Paravalvular Leak through a Mechanical Aortic Valve Prosthesis: 2 Successful Cases. Tex Heart Inst J (2016) 0.75

Combined Retrograde/Antegrade Approach to Transcatheter Closure of an Aortic Paravalvular Leak. Tex Heart Inst J (2015) 0.75

Paravalvular leak closure with two large size devices. Indian Heart J (2013) 0.75

Transcatheter closure of paravalvular leaks - how do I do it? Indian Heart J (2013) 0.75

Intraprocedural guidance: which imaging technique ranks highest and which one is complementary for closing paravalvular leaks? Cardiovasc Diagn Ther (2014) 0.75

Intravascular ultrasound for transcatheter paravalvular leak closure. Gen Thorac Cardiovasc Surg (2016) 0.75

Multi-Modality Imaging in the Evaluation and Treatment of Mitral Regurgitation. Curr Treat Options Cardiovasc Med (2017) 0.75

Transcatheter Aortic Valve Replacement: Outcomes, Indications, Complications, and Innovations. Curr Treat Options Cardiovasc Med (2017) 0.75

Articles by these authors

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr (2003) 5.03

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 4.34

2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.20

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59

Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation (2013) 3.28

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 2.91

Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90

Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol (2006) 2.83

Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation (2013) 2.83

Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv (2011) 2.63

One-year brain atrophy evident in healthy aging. J Neurosci (2009) 2.61

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol (2012) 2.41

Neuroanatomical assessment of biological maturity. Curr Biol (2012) 2.40

Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 2.37

Derivation of mean pulmonary artery pressure from noninvasive parameters. J Am Soc Echocardiogr (2013) 2.30

Late erosion of an Amplatzer septal occluder device 6 years after placement. J Thorac Cardiovasc Surg (2011) 2.26

Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp (2009) 2.24

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci (2010) 2.18

Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation (2007) 2.09

Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovasc Surg (2011) 2.08

Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation. Catheter Cardiovasc Interv (2013) 1.98

Double-orifice left atrioventricular valve in patients with atrioventricular septal defects: surgical strategies and outcome. Ann Thorac Surg (2012) 1.97

Surgical resection of ventricular cardiac fibromas: early and late results. Ann Thorac Surg (2003) 1.97

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail (2009) 1.87

Point-light biological motion perception activates human premotor cortex. J Neurosci (2004) 1.81

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. Cereb Cortex (2010) 1.79

Human cortical representations for reaching: mirror neurons for execution, observation, and imagery. Neuroimage (2007) 1.74

Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry (2010) 1.73

Hybrid intraoperative pulmonary artery stent placement for congenital heart disease. Am J Cardiol (2008) 1.72

Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med (2004) 1.70

Regional neocortical thinning in mesial temporal lobe epilepsy. Epilepsia (2008) 1.61

Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv (2007) 1.60

Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv (2011) 1.58

Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J Neurosci (2008) 1.57

Transcatheter closure of ischemic and post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv (2007) 1.54

Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy. Clin Cardiol (2009) 1.53

Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. Am J Cardiol (2010) 1.52

Complications associated with left ventricular puncture. Catheter Cardiovasc Interv (2010) 1.52

Multimodal imaging of the self-regulating developing brain. Proc Natl Acad Sci U S A (2012) 1.49

Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol (2011) 1.47

Genetic topography of brain morphology. Proc Natl Acad Sci U S A (2013) 1.46

Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience. JACC Cardiovasc Interv (2009) 1.45

Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med (2007) 1.45

Cortical thickness is influenced by regionally specific genetic factors. Biol Psychiatry (2009) 1.44

Bedside assessment of cardiac hemodynamics: the impact of noninvasive testing and examiner experience. Am J Med (2011) 1.44

Early and long-term results of the surgical treatment of tetralogy of Fallot with pulmonary atresia, with or without major aortopulmonary collateral arteries. J Thorac Cardiovasc Surg (2002) 1.41

Acute heart failure after percutaneous pulmonary valve (Melody valve) implantation. Congenit Heart Dis (2011) 1.41

Echocardiographic assessment of isolated pulmonary valve stenosis: which outpatient Doppler gradient has the most clinical validity? J Am Soc Echocardiogr (2005) 1.40

Transcatheter aortic valve insertion catastrophe in inoperable patients: should aortic valve replacement be denied? J Card Surg (2013) 1.39

Anatomy of the patent foramen ovale for the interventionalist. Catheter Cardiovasc Interv (2009) 1.38

Intraoperative transesophageal echocardiography during surgery for congenital heart defects. J Thorac Cardiovasc Surg (2002) 1.36

Subcortical and cerebellar atrophy in mesial temporal lobe epilepsy revealed by automatic segmentation. Epilepsy Res (2008) 1.35

Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.33

Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv (2007) 1.30

Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg (2010) 1.24

White matter tracts associated with set-shifting in healthy aging. Neuropsychologia (2009) 1.24

Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness. Cereb Cortex (2009) 1.23

Long-term influence of normal variation in neonatal characteristics on human brain development. Proc Natl Acad Sci U S A (2012) 1.23

Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology (2010) 1.22

Miniaturized transesophageal echocardiography in newborn infants. J Am Soc Echocardiogr (2002) 1.21

Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging (2010) 1.21

Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc (2004) 1.14

Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc (2004) 1.14

Intermediate follow-up following intravascular stenting for treatment of coarctation of the aorta. Catheter Cardiovasc Interv (2007) 1.13

Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology (2011) 1.13

A novel integrated MEG and EEG analysis method for dipolar sources. Neuroimage (2007) 1.13

MRI analysis in temporal lobe epilepsy: cortical thinning and white matter disruptions are related to side of seizure onset. Epilepsia (2011) 1.12

Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc (2006) 1.12

Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation (2007) 1.10

Brain development and aging: overlapping and unique patterns of change. Neuroimage (2012) 1.10

Thrombosis after septal closure device placement: a review of the current literature. Catheter Cardiovasc Interv (2004) 1.10

Multimodal imaging of repetition priming: Using fMRI, MEG, and intracranial EEG to reveal spatiotemporal profiles of word processing. Neuroimage (2010) 1.09

Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease. Neuropsychologia (2009) 1.08

Abdominal aortic pulsed wave Doppler patterns reliably reflect clinical severity in patients with coarctation of the aorta. Congenit Heart Dis (2008) 1.05

Fetal and neonatal presentation of noncompacted ventricular myocardium: expanding the clinical spectrum. J Am Soc Echocardiogr (2007) 1.05

Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev (2008) 1.01

Late outcomes of reintervention on the descending aorta after repair of aortic coarctation. Circulation (2010) 1.01

Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Catheter Cardiovasc Interv (2011) 1.01

Pathways to approval of pediatric cardiac devices in the United States: challenges and solutions. Pediatrics (2009) 0.99

Spatiotemporal dynamics of bilingual word processing. Neuroimage (2009) 0.97

Divergent cortical generators of MEG and EEG during human sleep spindles suggested by distributed source modeling. PLoS One (2010) 0.96

B-type natriuretic peptide and survival in hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 0.95

Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv (2007) 0.95